Beta Drugs 52-Week High & Low
Beta Drugs (BETA) 52-week high ₹2,668.30 (Aug. 11, 2026), 52-week low ₹1,030.30 (Feb. 25, 2026), current price ₹2,055.20 — 23.0% below 52-week high, 99.5% above 52-week low, range position 62.6% (Upper Range). For full fundamentals, ratios and live price, see BETA screener.
52-Week High
₹2,668.30
August 11, 2026
23.0% below high
52-Week Low
₹1,030.30
February 25, 2026
99.5% above low
Current Position in 52-Week Range
52W Low
62.6%
52W High
1638.00
Range Span (₹)
Upper Range
Position Category
62.6%
Range Position
Beta Drugs 52-Week Price Chart
BETA daily price over 52 weeks — current ₹2,055.20, high ₹2,668.30, low ₹1,030.30, range span ₹1638.00. Examine BETA quarterly results for recent quarterly revenue, profit and EPS trends.
Beta Drugs Historical 52-Week High & Low Ranges
BETA annual 52-week high, 52-week low and range span — 2 years of data. Check Beta Drugs marketcap in USD to track the company's total market size over time.
2026
52-Week Range
H: ₹2,668.30
L: ₹1,030.30
159.0% Range
2025
52-Week Range
H: ₹1,743.60
L: ₹1,512.80
15.3% Range
BETA vs Healthcare Sector — 52-Week Range Position & Return
Beta Drugs 52-week range position 62.6% vs Healthcare sector average 115.4%, avg 52-week return 78.2% — 6 peers.
115.4%
Sector Avg Position
78.2%
Sector Avg Return
6
Companies
Syngene Internation…
Position: 188.5% (Near High)
52W Return: 80.9%
SMS Lifesciences
Position: 109.7% (Near High)
52W Return: 75.0%
Aurobindo Pharma
Position: 102.5% (Near High)
52W Return: 63.8%
Divis Laboratories
Position: 99.0% (Near High)
52W Return: 70.6%
Sai Life Sciences
Position: 97.6% (Near High)
52W Return: 116.5%
Emcure Pharmaceutic…
Position: 95.1% (Near High)
52W Return: 62.5%
Volume Analysis at Extremes
High Volume: 100,763
(4.2x avg) - Strong buying interest at high - possible continuation
Low Volume: 28,458
(1.19x avg) - Normal volume at low - typical activity
Average Volume: 24,005